- Home
- SBFM vs BHFAN Comparison
SBFM vs BHFAN Comparison
Compare SBFM & BHFAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- BHFAN
- Stock Information
- Founded
- SBFM 2006
- BHFAN N/A
- Country
- SBFM United States
- BHFAN United States
- Employees
- SBFM N/A
- BHFAN 1400
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- BHFAN Life Insurance
- Sector
- SBFM Health Care
- BHFAN Finance
- Exchange
- SBFM Nasdaq
- BHFAN Nasdaq
- Market Cap
- SBFM 7.7M
- BHFAN N/A
- IPO Year
- SBFM N/A
- BHFAN N/A
- Fundamental
- Price
- SBFM $1.54
- BHFAN $15.34
- Analyst Decision
- SBFM Strong Buy
- BHFAN
- Analyst Count
- SBFM 1
- BHFAN 0
- Target Price
- SBFM $15.00
- BHFAN N/A
- AVG Volume (30 Days)
- SBFM 183.8K
- BHFAN N/A
- Earning Date
- SBFM 08-15-2025
- BHFAN N/A
- Dividend Yield
- SBFM N/A
- BHFAN N/A
- EPS Growth
- SBFM N/A
- BHFAN N/A
- EPS
- SBFM N/A
- BHFAN N/A
- Revenue
- SBFM $36,234,578.00
- BHFAN N/A
- Revenue This Year
- SBFM $192.48
- BHFAN N/A
- Revenue Next Year
- SBFM N/A
- BHFAN N/A
- P/E Ratio
- SBFM N/A
- BHFAN N/A
- Revenue Growth
- SBFM 35.51
- BHFAN N/A
- 52 Week Low
- SBFM $1.17
- BHFAN N/A
- 52 Week High
- SBFM $7.60
- BHFAN N/A
- Technical
- Relative Strength Index (RSI)
- SBFM 53.29
- BHFAN 41.17
- Support Level
- SBFM $1.42
- BHFAN $14.45
- Resistance Level
- SBFM $1.75
- BHFAN $16.40
- Average True Range (ATR)
- SBFM 0.12
- BHFAN 0.45
- MACD
- SBFM 0.01
- BHFAN -0.10
- Stochastic Oscillator
- SBFM 44.44
- BHFAN 43.89
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About BHFAN Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.